+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

In vitro activity of beta-lactam and non-beta-lactam antibiotics in extended-spectrum beta-lactamase-producing clinical isolates of Escherichia coli

In vitro activity of beta-lactam and non-beta-lactam antibiotics in extended-spectrum beta-lactamase-producing clinical isolates of Escherichia coli

Diagnostic Microbiology and Infectious Disease 54(2): 135-139

The activity of different beta-lactam and non-beta-lactam antibiotics was assessed against extended-spectrum beta-lactamase (ESBL) producing and non-ESBL-producing clinical isolates of Escherichia coli. A phenotypic study to discover the presence of ESBLs in 399 clinical isolates of E. coli was made by the disk diffusion method following the Clinical and Laboratory Standards Institute (formely NCCLS, 2004) guidelines.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 012190775

Download citation: RISBibTeXText

PMID: 16406187

DOI: 10.1016/j.diagmicrobio.2005.08.018

Related references

Activity of beta-lactam beta-lactamase inhibitor combinations against extended spectrum Beta-lactamase producing Enterobacteriaceae in urinary isolates. Journal of the College of Physicians and Surgeons--Pakistan 22(6): 358-362, 2012

Prevalence of the genes encoding extended-spectrum beta-lactamases, in Escherichia coli resistant to beta-lactam and non-beta-lactam antibiotics. Annals of Tropical Medicine and Parasitology 99(4): 413-417, 2005

Prevalence of gene(s) encoding extended spectrum beta lactamases (ESBL) in Escherichia coli resistant to beta lactam and non-beta lactam antibiotics. 2005

Activity in vitro of twelve antibiotics against clinical isolates of extended-spectrum beta-lactamase producing Escherichia coli. Journal of Basic Microbiology 47(5): 413-416, 2007

Antibacterial activity of beta-lactam antibiotics against extended-spectrum beta-lactamase producing bacteria. Japanese Journal of Antibiotics 52(9): 585-594, 1999

Bactericidal activity of oral beta-lactam antibiotics in plasma and urine versus isogenic Escherichia coli strains producing broad- and extended-spectrum beta-lactamases. International Journal of Antimicrobial Agents 25(6): 479-487, 2005

Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases. Antimicrobial Agents and ChemoTherapy 34(5): 858-862, 1990

Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum beta-lactamase-producing and extended-spectrum beta-lactamase-non-producing Escherichia coli isolates. Clinical Microbiology and Infection 16(2): 132-136, 2010

Quantitative analysis of beta-lactamase production of multiple resistance to beta-lactam antibiotics in clinical isolates of Escherichia coli. ChemoTherapy 28(1): 26-39, 1982

High frequency of beta-lactam susceptibility in CTX-M-type extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae, Escherichia coli and Proteus mirabilis according to the new CLSI recommendations. Journal of Antimicrobial ChemoTherapy 65(11): 2481-2483, 2010

In vitro activities of the potent, broad-spectrum carbapenem MK-0826 (L-749,345) against broad-spectrum beta-lactamase-and extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli clinical isolates. Antimicrobial Agents and ChemoTherapy 43(5): 1170-1176, 1999

Beta lactam antibiotics activity against escherichia coli omp f negative harboring extended spectrum beta lactamases. Program & Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 31: 117, 1991

In vitro activity of meropenem and seven other beta-lactam antibiotics against K.pneumoniae and enterobacteriaceae producing beta-lactamases with extended spectrum. Pathologie-Biologie 42(5): 365-368, 1994

In vitro activity of combinations of beta-lactam antibiotics with Ro 48-1220, a new beta-lactamase inhibitor, against beta-lactamase producing bacteria. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 34: 203, 1994

Resistance of Klebsiella pneumoniae strains producing and not producing ESBL (extended-spectrum beta-lactamase) type enzymes to selected non-beta-lactam antibiotics. Medical Science Monitor 8(3): Br100, 2002